ReviewPharmacoEconomics2021

Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Willem J A Witlox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.